New Exogen Competitor Approved

Discussion in 'Bioventus' started by anonymous, May 4, 2022 at 1:42 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    FDA approves Orthofix's ultrasonic bone fracture healing system

    "Developed by Orthofix Medical, the AccelStim system is a nonsurgical treatment designed to be worn for 20 minutes per day to repair fresh bone breaks and fractures that have not healed on their own.

    According to the company, its low-intensity pulsed ultrasound treatment, or LIPUS, delivers waves of pressure to the tissue to help speed up bone formation; in studies, fresh fractures healed 38% faster, and the device demonstrated an 86% overall success rate for previous fractures that had not fully healed."
     

  2. anonymous

    anonymous Guest

    Been trying to tell my friends at BV to be on the lookout. This is LIPUS competitor #2. Time to watch the ole BV Dance. Knee jerk reaction to market changes, never leading change. How’s that USA Shoulder indication for HA going? Supposed to have that a decade ago. Innovation, thy name isn’t Bioventus. Go buy another me too.